Pullareddy M

Pullareddy M has a diverse work experience spanning multiple companies and roles. Pullareddy started their career as a Graduate Trainee at Dr. Reddy's Laboratories in 2009. Pullareddy then worked as a Research Project Trainee at Sipra Labs Ltd, where they gained practical experience in various tasks related to BABE studies and clinical QA.

In 2012, Pullareddy joined Bomma Institute of Pharmacy as an Assistant Professor, teaching subjects like Anatomy Physiology, Health Education, and Pharmaceutical Analysis.

Pullareddy later returned to Sipra Labs Ltd, this time as a Medical Writer/CRA. In this role, they were responsible for the preparation of clinical study protocols, reports, abstracts, and other regulatory documents. Pullareddy also performed quality checks and maintained audit compliance.

In 2014, Pullareddy joined QPS Holdings, LLC as a Research Analyst, contributing to research activities within the company.

From 2015 to 2017, they worked at Kinapse as a Medical Writer Associate and later as a Senior Medical Writer Associate. In these roles, they authored and reviewed regulatory documents such as protocol registration forms and clinical study documents for regulatory submissions.

Since 2017, Pullareddy has been employed at Indegene, where they have held several roles. Pullareddy initially served as a Senior Scientific Writer, focusing on clinical disclosure and transparency activities. Pullareddy then progressed to a Team Lead position before assuming their current role as an Associate Manager. In their current role, they manage a team and is responsible for preparing and distributing global clinical trial application dossiers.

Overall, Pullareddy M has developed a strong background in medical writing, clinical trial management, research, and teaching throughout their career.

Pullareddy M has a B.Pharmacy degree in Pharmacy from Acharya Nagarjuna University. They also have an M.Pharm degree in Pharmacology from The Tamil Nadu Dr. M.G.R. Medical University. In addition, they have obtained certification as a RAPS Member from the Regulatory Affairs Certification Program in April 2023.